McKinley Capital Management’s Idexx Laboratories IDXX Stock Holding History

McKinley Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,108	Closed	-$6M	–	139
2024 Q1	$6M	Hold	11,108	–	–	0.72%	47
2023 Q4	$6.17M	Hold	11,108	–	–	0.79%	42
2023 Q3	$4.86M	Hold	11,108	–	–	0.68%	51
2023 Q2	$5.58M	Sell	11,108 -1,500	-12%	-$719K	0.75%	44
2023 Q1	$6.31M	Hold	12,608	–	–	0.84%	35
2022 Q4	$5.14M	Hold	12,608	–	–	0.69%	53
2022 Q3	$4.11M	Hold	12,608	–	–	0.56%	64
2022 Q2	$4.42M	Hold	12,608	–	–	0.58%	58
2022 Q1	$6.9M	Hold	12,608	–	–	0.69%	49
2021 Q4	$8.3M	Sell	12,608 -4,410	-26%	-$2.77M	0.74%	36
2021 Q3	$10.6M	Sell	17,018 -1,980	-10%	-$1.33M	1%	23
2021 Q2	$12M	Hold	18,998	–	–	0.84%	35
2021 Q1	$9.3M	Hold	18,998	–	–	0.7%	48
2020 Q4	$9.5M	Hold	18,998	–	–	0.68%	50
2020 Q3	$7.47M	Hold	18,998	–	–	0.58%	48
2020 Q2	$6.27M	Hold	18,998	–	–	0.43%	58
2020 Q1	$4.6M	Hold	18,998	–	–	0.37%	65
2019 Q4	$4.96M	Buy	+18,998	New	+$5.01M	0.32%	70
2019 Q3	–	Sell	-21,108	Closed	-$5.81M	–	193
2019 Q2	$5.81M	Buy	+21,108	New	+$5.2M	0.37%	65

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

McKinley Capital Management's IDXX Position: Q2 2024 in Review

McKinley Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 11,108 shares — an estimated $6M sold.

McKinley Capital Management first reported a position in IDXX in Q2 2019 and held it in 19 quarters. The position peaked at $12M in Q2 2021. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

McKinley Capital Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
McKinley Capital Management sold 11,108 Idexx Laboratories shares in Q2 2024, an estimated $6M.
McKinley Capital Management first reported a position in Idexx Laboratories in Q2 2019 and held it in 19 quarters.
McKinley Capital Management's Idexx Laboratories position peaked at $12M in Q2 2021.
1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.